만성폐쇄성폐질환 임상시험 결과
-
Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Sho
-
Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD
-
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patien
-
Tiotropium/Salmeterol Inhalation Powder in COPD
-
Risk Factors, Costs, and Impacts of ED Boarding
-
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
-
Anti-Platelets in Chronic Obstructive Pulmonary Disease
-
Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)
-
A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by M
-
Usability and Acceptability Study of the P-STEP Mobile Application
-
Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial
-
Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitatio
-
Functional Respiratory Imaging Study (DARWiIN)
-
COPD Access to Pulmonary Rehabilitation Intervention
-
Advance Care Planning in the Emergency Department
질환별 임상
폐암비소세포폐암유방암대장암위암간암췌장암전립선암난소암흑색종백혈병림프종다발성 골수종교모세포종제2형 당뇨병비만고혈압심부전심방세동뇌졸중만성 콩팥병비알코올 지방간염알츠하이머병파킨슨병다발성 경화증우울증뇌전증루게릭병류마티스 관절염건선아토피 피부염크론병궤양성 대장염루푸스천식만성폐쇄성폐질환